Stromal cell-derived factor-1 (CXCL12) activates integrins by direct binding to an allosteric ligand-binding site (site 2) of integrins without CXCR4

Abstract

Leukocyte arrest on the endothelial cell surface during leukocyte extravasation is induced by rapid integrin activation by chemokines. We recently reported that fractalkine induces integrin activation without its receptor CX3CR1 through binding to the allosteric site (site 2) of integrins. Peptides from site 2 bound to fractalkine and suppressed integrin activation by fractalkine. We hypothesized that this is not limited to membrane-bound fractalkine. We studied whether stromal cell-derived factor-1 (SDF1), another chemokine that plays a critical role in leukocyte arrest, activates integrins through binding to site 2. We describe here that (1) SDF1 activated soluble integrin αvβ3 in cell-free conditions, suggesting that SDF1 can activate αvβ3 without CXCR4; (2) site 2 peptide bound to SDF1, suggesting that SDF1 binds to site 2; (3) SDF1 activated integrins αvβ3, α4β1, and α5β1 on CHO cells (CXCR4-negative) and site 2 peptide suppressed the activation; (4) A CXCR4 antagonist AMD3100 did not affect the site 2-mediated integrin activation by SDF1; (5) Cell-surface integrins were fully activated in 1 min (much faster than activation of soluble αvβ3) and the activation lasted at least for 1 h. We propose that the binding of SDF1 to cell-surface proteoglycan facilitates the allosteric activation process; (6) Mutations in the predicted site 2-binding site in SDF1 suppressed integrin activation. These results suggest that SDF1 (e.g. presented on proteoglycans) can rapidly activate integrins in an allosteric manner by binding to site 2 in the absence of CXCR4. The allosteric integrin activation by SDF1 is a novel target for drug discovery.

Embryo-Derived Chemokine CXCL12 Enhances Pregnancy Outcome via Improvement of Endometrial Receptivity

“…Additionally, the expression levels of integrin αvβ3 and HIF1α, surrogate markers of endometrial receptivity, were dramatically increased in Ishikawa cells upon CXCL12 treatment (Fig. 1e), which are consistent with previously reported ndings [36,37]. In particular, both expressions of integrin αvβ3 and HIF1α were elevated in the cytoplasmic compartment.…”

Phosphorylation inhibition of protein-tyrosine phosphatase 1B tyrosine-152 induces bone regeneration coupled with angiogenesis for bone tissue engineering

“…Consistent with previous studies, the 152RM peptide rapidly activates the phosphorylation of FAK, leading to dissociation of the cadherin complex and initiation of MSC departure from stem cell niches [ 44 ]. CXCl12/CXCR4 can directly activate the integrin αvβ3 signaling pathway and then promote cell migration [ 45 ]. Activation of integrin αvβ3 is associated with invasion and metastasis of multiple tumors [ 46 ].…”

Multifunctional coatings combining bioactive peptides and affinity-based cytokine delivery for enhanced integration of degradable vascular grafts

“…While CXCL12 promotes anti-apoptotic signaling through its CXCR7 receptor, 53,54 it also activates α V β 3 integrins by allosteric modulation. 55 Cell surface proteoglycans mediate this interaction, stressing again the interplay between adhesion ligands, GAGs and modulator proteins within the ECM. Combining all of these components in a functional biomaterial coating can induce cooperativity and further enhance the regeneration process.…”